-+ 0.00%
-+ 0.00%
-+ 0.00%

Aura Biosciences Q2 EPS $(0.48) Misses $(0.38) Estimate

Benzinga·08/11/2026 11:22:23
Listen to the news
Aura Biosciences (NASDAQ:AURA) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.38) by 29.73 percent. This is a 2.13 percent decrease over losses of $(0.47) per share from the same period last year.